Loading...

TG Therapeutics, Inc.

0VGI.L•LSE
Healthcare
Medical - Pharmaceuticals
£28.07
£-9.43(-25.15%)

TG Therapeutics, Inc. (0VGI.L) Stock Overview

Explore TG Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 73.5/100

Key Financials

Market Cap4.5B
P/E Ratio69.75
EPS (TTM)$-2.46
ROE0.29%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$39.00

0VGI.L Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of TG Therapeutics, Inc. (0VGI.L) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 0.00, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $39.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 69.75 and a market capitalization of 4.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-4.51%
3-Month Change
-6.71%
6-Month Change
42.72%
Year-to-Date (YTD) Change
3.03%
1-Year Change
80.93%
3-Year Change
212.98%
5-Year Change
164.96%
All-Time (Max) Change
164.96%

Contact Information

https://www.tgtherapeutics.com
212 554 4484
2 Gansevoort Street, Morrisville, NY, 10014

Company Facts

352 Employees
IPO DateNov 23, 2018
CountryUS

Frequently Asked Questions

;